These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5088897)

  • 1. [Action of orciprenaline on uterine contractility].
    Guevara-Rubio G; Castillo Sosa ML; Karchmer S; Guzmán Sánchez A
    Ginecol Obstet Mex; 1971 Mar; 29(173):301-18. PubMed ID: 5088897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic studies with the p-hydroxyphenyl derivative of orciprenaline].
    Lichtlen P; Stutz R
    Arzneimittelforschung; 1969 Feb; 19(2):147-9. PubMed ID: 5818751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Orciprenaline and theophylline effect on the circulatory system during ergometer stress].
    Meier G; Schümann R
    Med Klin; 1969 Apr; 64(15):689-92. PubMed ID: 5783030
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative beta-adrenoceptive stimulant properties of salbutamol (AH 3365), orciprenaline and soterenol (MJ 1992).
    Farmer JB; Levy GP
    Br J Pharmacol; 1969 Feb; 35(2):P358-9. PubMed ID: 5774057
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience in the use of orciprenaline (Alupent) as an inhibitor of uterine contractility].
    Chargoy Vera J; Hoyo Garza R; Tapia Ruiz JA
    Ginecol Obstet Mex; 1971 Jan; 29(171):81-9. PubMed ID: 5087982
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol.
    Brittain RT
    Postgrad Med J; 1971 Mar; 47():Suppl:11-6. PubMed ID: 5572509
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of the contractility of the uterus in threatened premature labor using orciprenaline (Alupent). Preliminary report].
    Cobo E; Kafury S
    Rev Colomb Obstet Ginecol; 1970; 21(2):111-7. PubMed ID: 5450670
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effects of inotropic substances on the heart dynamics and peripheral blood circulation].
    Schüren KP; Buschmann J; Meyer V; Schröder R
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():206-13. PubMed ID: 4899541
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spirometric study of the normal human expiratory bronchial tone by the use of metaproterenol].
    Reyes AJ; Elena R; Catalá G; López J
    Prensa Med Argent; 1967 Aug; 54(26):1274-81. PubMed ID: 5603131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative evaluation of the bronchodilator effects and cardiovascular effects of 3 beta adrenergic stimulants in bronchial asthma--comparison of isoproterenol, metaproterenol and salbutamol].
    Matsumoto S; Tanaka Y; Wagatsuma Y; Miura R; Umezu A
    Arerugi; 1971 Aug; 20(8):599-609. PubMed ID: 4398383
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiovascular action of orciprenaline in the pregnant woman and the fetus].
    Guevara Rubio G; Castillo Sosa ML; Smith HC; Karchmer S
    Ginecol Obstet Mex; 1972 Apr; 31(186):389-95. PubMed ID: 5028606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Orciprenaline (Alupent) for pharmacological relaxation of the uterus during labor].
    Melander S
    Nord Med; 1971 Aug; 86(33):985. PubMed ID: 5094859
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of some sympathomimetic amines on the coronary resistance in the dog heart in situ during heart beat and asystole].
    Bassenge E; Doutheil U
    Arzneimittelforschung; 1970 Mar; 20(3):343-7. PubMed ID: 4392592
    [No Abstract]   [Full Text] [Related]  

  • 14. Action of orciprenaline on uterine contractility during labor, maternal cardiovascular system, fetal heart rate, and acid-base balance.
    Zilianti M; Aller J
    Am J Obstet Gynecol; 1971 Apr; 109(7):1073-9. PubMed ID: 5552643
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of orciprenaline in the last stage of dilatation in labor].
    Lima JR; Montenegro CA; Yamashiro RT
    Matern Infanc (Sao Paulo); 1972; 31(1):43-51. PubMed ID: 5049154
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of orciprenaline as an inhibitor of uterine contractility].
    Soto Yances A
    Rev Colomb Obstet Ginecol; 1970; 21(3):219-31. PubMed ID: 5505816
    [No Abstract]   [Full Text] [Related]  

  • 17. [Which beta-adrenergic agent should be used for the inhibition of labor (Berotec, Ritodrine, Dilatol)?].
    Hüter J; Rippert C; Meyer C
    Geburtshilfe Frauenheilkd; 1972 Feb; 32(2):97-103. PubMed ID: 4401339
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of 1-(3,5-dihydroxyphenyl)-2-isopropylamino-ethanol sulfate on respiratory function and heart minute volume].
    Demiroglu C; Göksel F; Oztürk M; Obek A
    Arzneimittelforschung; 1968 Jun; 18(6):682-5. PubMed ID: 5756045
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibition of the contractility of the pregnant human uterus through the use of orciprenaline sulfate and Th-1165].
    Cobo E; Kafury S
    Rev Colomb Obstet Ginecol; 1970; 21(3):271-2. PubMed ID: 5505819
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beta-receptors and renal hemodynamics in humans].
    Schirmeister J; Decot M; Hallauer W; Willmann H
    Arzneimittelforschung; 1966 Jul; 16(7):847-50. PubMed ID: 6014712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.